2591 — Guangzhou Innogen Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$8.77bn
- HK$7.58bn
- CNY131.51m
Annual cashflow statement for Guangzhou Innogen Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | IFRS | IFRS | — |
| Status: | Final | Final | fx Preliminary |
| Net Income/Starting Line | -733 | -175 | — |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 525 | 1.51 | — |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 23.7 | -6.37 | — |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -165 | -163 | — |
| Capital Expenditures | -12.2 | -4.33 | — |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -145 | 280 | — |
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -157 | 276 | — |
| Financing Cash Flow Items | -11.7 | -3.26 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 352 | 255 | — |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 30.6 | 369 | — |